Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1278
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | ||
| NCT04197310 | Cabozantinib and Nivolumab for Carcinoid Tumors | ||
| NCT05767359 | CAR- PRISM (PRecision Intervention Smoldering Myeloma) | ||
| NCT00496379 | ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases | ||
| NCT03391362 | Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases | ||
| NCT00126191 | Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | ||
| NCT05617885 | Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | ||
| NCT02340676 | A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD | ||
| NCT00137774 | Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors | ||
| NCT06317220 | Vedolizumab for the Treatment of Collagenous Gastritis | ||
| NCT02943642 | Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides | ||
| NCT00593008 | Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | ||
| NCT06623110 | Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease | ||
| NCT00165360 | Prolonged Daily Temozolomide for Low-Grade Glioma | ||
| NCT03661723 | Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma | ||
| NCT01058655 | RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer | ||
| NCT05759143 | Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing | ||
| NCT05922761 | BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) | ||
| NCT02141542 | Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma | ||
| NCT04417062 | Olaparib With Ceralasertib in Recurrent Osteosarcoma | ||
| NCT00928018 | Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma | ||
| NCT06001762 | TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer | ||
| NCT04045470 | A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma | ||
| NCT03833934 | Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance | ||
| NCT05225428 | Video Education With Result Dependent dIsclosure | ||
| NCT06208748 | SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST | ||
| NCT02666378 | Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer | ||
| NCT02853500 | Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies | ||
| NCT01790932 | BKM120 For Triple Negative Breast Cancer | ||
| NCT01623349 | Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer | ||
| NCT00894855 | Skin Cancer Screening and Education at Beaches | ||
| NCT01982448 | Cisplatin vs Paclitaxel for Triple Negative Breast Cancer | ||
| NCT00936858 | RAD001 for Patients With Radioiodine Refractory Thyroid Cancer | ||
| NCT00470847 | Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer | ||
| NCT00330252 | Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL | ||
| NCT00116142 | Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer | ||
| NCT02257541 | BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) | ||
| NCT00165451 | A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer | ||
| NCT00215501 | Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | ||
| NCT00047281 | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma | ||
| NCT02478164 | Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma | ||
| NCT00644202 | A Pilot Weight Control Intervention at HPHC | ||
| NCT05587439 | Investigating Hereditary Risk In Thoracic Cancers (INHERIT) | ||
| NCT01049230 | Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors | ||
| NCT03130439 | Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer | ||
| NCT02285439 | Study of MEK162 for Children With Low-Grade Gliomas | ||
| NCT00776594 | Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy | ||
| NCT02279394 | E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma | ||
| NCT03125239 | Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT03571841 | Sexual Health and Rehabilitation After Ovarian Suppression Treatment |
